A report from the CDC shows cervical precancerous lesions dropped 80% in 20-24 year old women screened for cervical cancer ...
Genmab's Tivdak wins Japan's approval for advanced cervical cancer after a Phase 3 trial showed improved survival over chemotherapy.
Funding will support Moores Cancer Center’s efforts to develop a unique, large-scale program to drive early detection and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback